This picture could be integrated with a peripheral CD4 and CD8 immune response deficiency in patients with mild COVID-19 symptoms compared to patients with moderate/severe symptoms, as reported very recently by Bukowska-Ośko et al. [28]. This evidence concerns the gene CD8A and COVID-19.